Bifogade filer
PDF
Kurs
-6,17%
Kurs
-6,17%
Open
23,33
High
23,62
Low
21,61
Close
21,89
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
1,40 MNOK
Likviditet
1,40 MNOK
Rel. mcap
2,17%
Antal aktier
62 879
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2025-08-28 | 18:50 | Kvartalsrapport 2025-Q2 |
| 2025-06-06 | N/A | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2025-06-05 | N/A | Årsstämma |
| 2025-04-10 | - | Bokslutskommuniké 2024 |
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-19 | - | Årsstämma |
| 2024-06-06 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2024-04-25 | - | Bokslutskommuniké 2023 |
| 2023-10-04 | - | Split CRNA 30:1 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-22 | - | Årsstämma |
| 2023-04-21 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2023-03-09 | - | Extra Bolagsstämma 2023 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-11-03 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-20 | - | Årsstämma |
| 2022-04-07 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-25 | - | Extra Bolagsstämma 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-18 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-18 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2021-03-17 | - | Årsstämma |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-11-05 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-30 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2020-04-29 | - | Årsstämma |
| 2020-03-11 | - | Bokslutskommuniké 2019 |
| 2019-11-07 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-09 | - | Kvartalsrapport 2019-Q1 |
| 2019-04-10 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2019-04-09 | - | Årsstämma |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-11-01 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-23 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-03 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-12 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2018-04-11 | - | Årsstämma |
| 2018-02-15 | - | Bokslutskommuniké 2017 |
| 2017-11-16 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-25 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-05 | - | Årsstämma |
| 2017-02-16 | - | Bokslutskommuniké 2016 |
| 2016-11-17 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-12 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-14 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2016-04-13 | - | Årsstämma |
| 2015-06-23 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2015-06-22 | - | Årsstämma |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2023-03-02 13:24:58
Oslo, 2 March 2023: Reference is made to Targovax ASA's ("Targovax" or the "Company") stock exchange announcement published on 2 March 2023, regarding the board of directors' resolution to increase the Company's share capital with NOK 10,378.90 by the issuance of 103,789 new shares, each with a nominal value of NOK 0.10, in order to facilitate an exercise of 103,789 RSUs pursuant to the Company's RSU program for Board members.
- Primary insider, Diane Mellett, member of the board of directors, has exercised 20,870 restrictive stock units ("RSUs") under her RSU agreement and subscribed for 20,870 new shares in the Company following the exercise of RSUs. The exercise price for the options was NOK 0.10 per new share.
- Primary insider, Robert Burns, member of the board of directors, has exercised 23,307 restrictive stock units ("RSUs") under his RSU agreement and subscribed for 23,307 new shares in the Company following the exercise of RSUs. The exercise price for the options was NOK 0.10 per new share.
- Primary insider, Damian Marron, member of the board of directors, has exercised 55,588 restrictive stock units ("RSUs") under his RSU agreement and subscribed for 55,588 new shares in the Company following the exercise of RSUs. The exercise price for the options was NOK 0.10 per new share.
- Primary insider, Eva-Lotta Allan, member of the board of directors, has exercised 4,024 restrictive stock units ("RSUs") under her RSU agreement and subscribed for 4,024 new shares in the Company following the exercise of RSUs. The exercise price for the options was NOK 0.10 per new share.
- Diane Mellett holds 122,948 shares, 104,388 RSUs and nil options in Targovax.
- Robert Burns holds 298,761 shares, 43,071 RSUs and nil options in Targovax.
- Damian Marron holds 55,588 shares, 97,765 RSUs and nil options in Targovax.
- Eva-Lotta Allan holds 98,883 shares, 64,469 RSUs and nil options in Targovax.
Please refer to the attached notification of trading for further details.
Notification by Primary Insiders 02.03.23.docx.pdf (https://mb.cision.com/Public/17093/3726627/8ed179f09261c940.pdf)
For further information, please contact:
Erik Digman Wiklund, CEO
Phone: +47 413 33 536
Email: erik.wiklund@targovax.com
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: renate.birkeli@targovax.com
Media enquires:
Andreas Tinglum - Corporate Communications (Norway)
Phone: +47 9300 1773
Email: andreas.tinglum@corpcom.no